FEB 23, 2017 1:25 PM PST

"STING" Protein Activates As Immune Cells Recognize Viral DNA

WRITTEN BY: Kara Marker

Scientists keep chipping away at the mysteries of the immune system, and this time in a new study published in Nature Communications, they discovered two new proteins involved in the innate immune response to foreign DNA.

A DNA virus has DNA as its genetic material and replicates using DNA-dependent DNA polymerase. Source: Tech Times

Immune cells might recognize DNA as foreign if it is cancerous or from a virus, and from the moment of recognition, cells burst into action, triggering a domino effect of reactions that begin with the production of interferon, signaling to nearby cells that foreign DNA is in their midst.

From a research team at Aarhus University, experts found a new protein playing vital role in the domino effect: “STING.” This protein acts as an immunological doorknob to initiate interferon and chemical messenger production in response to the detection of foreign DNA floating around outside of the cell.

During their study, researchers investigated the function of STING in immune cells called macrophages which engulf and destroy foreign invaders. One by one, they deleted macrophage genes to see if their absence had any effect on STING function. This is where they identified that the gene coding for another protein, called IFI16, was necessary for macrophages to produce interferon in response to tumor or viral DNA.

“IFI16, which most of our immune cells carry, has crucial significance for the cell's defense against microorganisms or dying cells' release of DNA," explained study researcher Martin Roelsgaard Jakobsen.

Comprehending the role of both IFI16 and STING has implications for cancer immunotherapy, new antiviral strategies, and even autoimmune disease treatment.

"STING's function and its degree of activity play a significant role in how well the body fights conditions when it is exposed to something that is foreign or abnormal such as infections and cancer," Jakobsen explained. "By using different molecular biological methods, we could clearly demonstrate that our immune cells only need a very small fraction of the IFI16 protein for STING to function optimally.”

Jakobsen and his team hope to develop new immunotherapy tactics based on manipulating STING within the next few years. The plan of action, he said, would be to “go directly in and boost the innate immune defense system in the cancerous tumor by using molecules that targets and triggers STING and IFI16 function.”

Source: Aarhus University

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 14, 2021
Immunology
'Bio-Betters' Form the Next Wave of Cancer Therapies
OCT 14, 2021
'Bio-Betters' Form the Next Wave of Cancer Therapies
  Antibodies are blood proteins with highly specialized functions: to recognize and eliminate bacteria, viruses, an ...
OCT 17, 2021
Cardiology
Flu Vaccination Significantly Reduces Risk of Cardiac Events
OCT 17, 2021
Flu Vaccination Significantly Reduces Risk of Cardiac Events
The flu has been associated with a significantly increased risk of a cardiac event like heart attack or stroke.
NOV 04, 2021
Cancer
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
NOV 04, 2021
Giving the Immune System a Kickstart to Improve Immunotherapy Efficacy
Despite the incremental success immune checkpoint inhibitors (ICI) have attributed to the cancer treatment landscape rec ...
DEC 11, 2021
Health & Medicine
The Vaccinated Can Still Get Long COVID
DEC 11, 2021
The Vaccinated Can Still Get Long COVID
Those who suffer from long COVID have persistent or new symptoms that weren't present during acute infection with SA ...
JAN 07, 2022
Cancer
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
JAN 07, 2022
Crossing the Blood-Brain Barrier: Improving Experimental Models to Study Drug Delivery
The blood-brain barrier (BBB) describes the complex vasculature network that delivers oxygen and nutrients to the brain. ...
JAN 14, 2022
Drug Discovery & Development
Repurposing Drugs 101
JAN 14, 2022
Repurposing Drugs 101
Drug development is expensive. Taking into account costs of failed trials, the average drug costs $985 million to resear ...
Loading Comments...